Law school enrollment plummets to 27-year low, ABA says
Total law school enrollment at the 204 accredited schools is 119,775, a 6.9-percent decrease from last year and an 18-percent decrease from its record high in 2010.
Total law school enrollment at the 204 accredited schools is 119,775, a 6.9-percent decrease from last year and an 18-percent decrease from its record high in 2010.
West Virginia University Athletic Director Oliver Luck, the father of Colts QB Andrew Luck, is joining the Indianapolis-based NCAA as executive vice president of regulatory affairs.
Apple Inc. quickly dispensed with a $1 billion lawsuit by iPod users claiming software updates for the device were meant to block competitors, as a jury ruled for the company after only three hours of deliberations.
John Pistole, outgoing head of the Transportation Security Administration and soon-to-be president of Anderson University, said the greatest threat to national security is still someone slipping a bomb onto a plane bound for the United States.
While the tests will likely help drug companies like Eli Lilly and Co. evaluate medicines, they’ll also create wrenching personal and ethical dilemmas for patients who will have to live with the knowledge that they’re destined to develop the disease.
A Covance Inc. investor contends in a lawsuit that the drug-testing company’s board erred in relying on what the shareholder called Goldman Sachs Group Inc.’s conflict-tainted advice. Covance has major laboratory operations in Indianapolis.
If approved, Baricitinib may bring Lilly $673 million in 2020, according to the average of five analysts’ estimates compiled by Bloomberg.
Avanir Pharmaceuticals Inc. has reached a The Aliso Viejo, California-based company, which makes a drug to control symptoms of Alzheimer’s disease, this week agreed to sell itself to Japan’s Otsuka Holdings Co. for $3.2 billion, or $17 a share. That’s 4 percent lower than analysts’ average projection for where the stock would have traded in […]
Biogen Idec Inc. shares rose Tuesday after the company said its Alzheimer’s drug showed promising early results and will be quickly moved into a final-stage trial.
A major drugmaker that was part of three-way multi-billion-dollar deal this year involving Eli Lilly and Co. is planning a reorganization that will include hundreds of job cuts in the United States.
John Tague, who spent more than a decade in executive leadership at now-defunct Indianapolis airline company ATA Holdings Corp., has landed at another type of transportation company.
New Jersey was the third state after Illinois and Indiana to bet that outside marketing and sales experts could tap hidden lottery riches. The state uses the same private manager as Indiana.
Indianapolis-based Simon Property Group Inc. said it has accumulated a 3.6-percent stake in shopping mall rival Macerich Co. and wants to buy more shares.
The results have immediate implications for 1 million Americans who suffer mild heart attacks or chest pain each year. They may also make it easier for other experimental medicines from companies such as Eli Lilly to reach patients.
With help from companies like Indianapolis-based CMG Worldwide, deceased icons like James Dean, Michael Jackson, Elvis Presley and Amelia Earhart are enjoying unprecedented success, out-earning even their former flesh-and-blood selves.
Federal Reserve Bank of St. Louis President James Bullard said market-based measures of inflation expectations have declined to low levels in recent months but have rebounded since mid-October.
Employers have now added at least 200,000 jobs for nine straight months, the longest such stretch since 1995.
The global firm is planning 2,600 job cuts over 18 months, primarily in its aerospace division. Its Indianapolis operations, which employ about 4,500 people, are devoted mostly to civil and defense aerospace work.
While foes of the Affordable Care Act warned of double-digit rate increases, the costs of premiums seen so far is more modest for the new year.
Eli Lilly and Co. would be a logical acquirer for the maker of a drug that could treat agitation in Alzheimer’s patients.